Ligand validation:4CT2

DTD: DITHIANE DIOL

DTD is a Ligand Of Interest in 4CT2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CT2_DTD_A_600	59%	52%	0.14	0.921	0.4	1.43	-	2	0	0	100%	0.83
5LVN_DTD_A_401	77%	0%	0.09	0.93	8.06	1.48	6	2	1	0	100%	1
5LVM_DTD_A_402	60%	34%	0.125	0.911	0.96	1.61	-	2	0	0	100%	1
4AW0_DTD_A_900	52%	15%	0.129	0.885	2.32	1.5	2	-	2	0	100%	1
5ACK_DTD_A_700	49%	22%	0.126	0.872	0.62	2.54	-	3	1	0	100%	1
4CT1_DTD_A_800	46%	34%	0.17	0.907	0.43	2.13	-	3	0	0	100%	1
4JJ7_DTD_A_602	95%	42%	0.079	0.981	1.18	1.08	1	-	0	0	100%	1
2IZX_DTD_A_1045	91%	9%	0.074	0.961	0.9	3.45	-	3	0	0	100%	1
3MZ9_DTD_B_505	90%	29%	0.091	0.974	1.31	1.54	1	1	1	0	100%	0.9
5P9O_DTD_A_304	90%	14%	0.083	0.964	1.38	2.42	1	3	0	0	100%	0.5
3MZB_DTD_B_508	88%	42%	0.082	0.956	1.07	1.16	1	1	1	0	100%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.